FDA Inspection
BloodworksBloodworks – FDA Inspection, Nov 2, 2017
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on November 2, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 28b8eca4-785d-4248-8587-48b8d7d2bd53
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1031409
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Bloodworks
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 15, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 14, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Bloodworks
- FDA Inspection 1312856 - 2026-04-15
- FDA Inspection 1167416 - 2022-03-15
- FDA Inspection 904964 - 2014-11-28
- FDA Inspection 812004 - 2012-12-13
- FDA Inspection 749837 - 2011-10-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.